**Introduction:** Gout is the most common inflammatory arthritis, and is known to only rarely co-exist with rheumatoid arthritis. We present the case of a 59-year-old male with longstanding rheumatoid factor (RF) positive, anti cyclic citrullinated peptide antibody (ACPA) positive rheumatoid arthritis on treatment with tocilizumab monotherapy, who presented with an acute ankle arthritis and normal inflammatory markers.

**Case description:** A 59-year-old Caucasian man presented with worsening severe right ankle pain on a background of a longstanding history of seropositive, ACPA positive rheumatoid arthritis, originally diagnosed in 1986. His comorbidities included obesity, non-alcoholic fatty liver disease, peripheral neuropathy, and previous spinal surgery. He was admitted acutely with a 7 day history of a painful, swollen and erythematous right ankle, struggling to weight-bear. Prior to this admission, his rheumatoid arthritis had been well-controlled with tocilizumab monotherapy for several years. His initial observations were; temperature 36.2 oC, BP 135/80, pulse 110/min, respiratory rate 17/min, oxygen saturations 94% on room air. General physical examination was unremarkable other than a known peripheral neuropathy. Musculoskeletal examination revealed; a moderate, cool, right knee effusion, a significantly warm right swollen ankle with painful restricted movements and no other active rheumatoid arthritis features. Neurological examination revealed longstanding reduced sensation to pain, light touch and temperature in the lower limbs. The patient noted the right ankle to be 'cold'. The serum urate was elevated at 726 (\<410 micromol/L). However the rest of the blood tests and inflammatory markers were normal; CPR \<1mmol/L; ESR 5mm/hr (\<20); WCC 4.1 x109/L; neutrophils 2.0 x109/L. Radiographs were non-diagnostic, and did not show chondrocalcinosis. An ultrasound of the right ankle showed mild synovitis, a small effusion, and tenosynovitis in the medial ankle tendons that contained echogenic debris. There was no cartilage in the right first MTP joint, so no assessment for a 'double contour sign' could be made. Approximately 0.1ml of thick fluid was aspirated from the ankle joint under direct ultrasound guidance. To prevent immediate clot formation the synovial fluid was diluted with 1ml of sterile water. The right knee was also aspirated, yielding 12ml clear synovial fluid. Cytology examination of the ankle fluid revealed needle-shaped negatively birefringent crystals consistent with gout, with no crystals in the knee synovial fluid. He was treated with 80mg of intramuscular triamcinolone acetonide, colchicine, and commenced on allopurinol. He was discharged with a plan for uricosuric therapy, lifestyle modification, and analgesia.

**Discussion:** Tocilizumab is an interleukin-6 blocking therapy used to treat rheumatoid arthritis. To our knowledge, this is the first case report describing acute gout occurring in a patient with rheumatoid arthritis established on tocilizumab therapy. Several case reports describe the improvement of resistant gout with tocilizumab therapy, making this case potentially more unusual. Tocilizumab suppresses traditional acute phase proteins such as CRP and ESR, typically complicating the assessment for infection, and in this case gout. Small volumes of synovial fluid can clot before laboratory assessment, the use of sterile water in this case allowed rapid microscopy.

**Key learning points:** Tocilizumab can mask an acute phase response in crystal arthropathies as well as infection. Gout and rheumatoid arthritis can coexist, synovial fluid analysis can help resolve diagnostic uncertainty Crystal analysis of small volumes of synovial fluid (\<0.1ml) can still be diagnostic. Dilution of a sample with sterile water can prevent clot formation in small volumes of synovial fluid. Ultrasound, with guided aspiration can help suggest and confirm crystal arthritis.
